DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Herceptin (Trastuzumab) - Hospitalization - Suspected Cause - Side Effect Reports

 
 



Index of reports > Hospitalization (760)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Herceptin (Trastuzumab) hospitalization. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 760   Next >>

Possible Herceptin side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-24

Patient: female

Reactions: Breast Pain, Pruritus, Drug Ineffective, Pain, Breast Mass, Feeling Cold, Malaise, Nodule, Pulmonary Oedema, Lacrimation Increased, Infusion Related Reaction

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin
    Indication: Breast Cancer
    Start date: 2006-08-01

Perjeta
    Indication: Breast Cancer

Other drugs received by patient: Carboplatin; Taxotere; Tykerb



Possible Herceptin side effects in female

Reported by a individual with unspecified qualification from Colombia on 2012-08-23

Patient: female

Reactions: Supraventricular Tachycardia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin



Possible Herceptin side effects in female

Reported by a consumer/non-health professional from Slovakia (Slovak Republic) on 2012-08-23

Patient: female

Reactions: Suicidal Ideation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin



Possible Herceptin side effects in female

Reported by a physician from Germany on 2012-08-23

Patient: female, weighing 75.0 kg (165.0 pounds)

Reactions: Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: 5 auc
    Indication: Breast Cancer
    Start date: 2012-04-25

Docetaxel
    Indication: Breast Cancer
    Start date: 2012-04-25

Herceptin
    Indication: Breast Cancer
    Start date: 2012-04-25

Herceptin

Placebo
    Indication: Breast Cancer
    Start date: 2012-04-25

Other drugs received by patient: Metoprolol Tartrate



Possible Herceptin side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23

Patient: female, weighing 69.6 kg (153.2 pounds)

Reactions: Vomiting, Metabolic Acidosis, Diarrhoea, Nausea, Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Docetaxel
    Indication: Breast Cancer
    Start date: 2012-06-18
    End date: 2012-06-18

Herceptin
    Indication: Breast Cancer
    Start date: 2012-06-18
    End date: 2012-06-18

Pertuzumab
    Indication: Breast Cancer
    Start date: 2012-06-18
    End date: 2012-06-18

Other drugs received by patient: Neulasta; Taxol



Possible Herceptin side effects in 61 year old female

Reported by a physician from France on 2012-08-23

Patient: 61 year old female

Reactions: Jaundice, Hepatitis Cholestatic

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Femara
    Administration route: Oral
    Indication: Breast Cancer Metastatic

Herceptin
    Indication: Breast Cancer Metastatic

Lapatinib
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    End date: 2011-08-06



Possible Herceptin side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-22

Patient: male, weighing 89.9 kg (197.8 pounds)

Reactions: Vomiting, Dyspnoea, Nausea, Dehydration, Pneumomediastinum, Pneumothorax, Odynophagia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Avastin
    Indication: Oesophageal Cancer Metastatic
    Start date: 2011-05-17
    End date: 2011-11-15

Avastin
    Dosage: last dose recieved on 14 feb 2012
    End date: 2012-02-14

Herceptin
    Dosage: last dose recieved on 14 feb 2012.
    End date: 2012-02-14

Herceptin
    Dosage: last dose recieved on 14 feb 2012.
    Indication: Oesophageal Cancer Metastatic
    Start date: 2011-05-10
    End date: 2011-11-15

Oxaliplatin
    Indication: Oesophageal Cancer Metastatic
    Start date: 2011-05-17
    End date: 2011-11-15

Oxaliplatin
    End date: 2012-02-14

Xeloda
    End date: 2012-02-26

Xeloda
    Indication: Oesophageal Cancer Metastatic
    Start date: 2011-05-17
    End date: 2011-11-29

Other drugs received by patient: Actos; Lorazepam; DTO; Prilosec; Ritalin; Toprol-XL; Potassium Chloride; Lomotil; Dexamethasone; Compazine; Prednisone TAB; Citalopram Hydrobromide; Morphine Sulfate; Lisinopril; Metoprolol Tartrate; Dicyclomine; Methylphenidate; Zofran; Oxycodone HCL; Decadron Phosphate; Bentyl; Emend



Possible Herceptin side effects in female

Reported by a physician from China on 2012-08-22

Patient: female, weighing 50.0 kg (110.0 pounds)

Reactions: Upper Gastrointestinal Haemorrhage

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Epirubicin Hydrochloride
    Dosage: most recent dose prior to ae onset on 30/jul/2012
    Indication: Breast Cancer
    Start date: 2012-05-05
    End date: 2012-08-14

Herceptin
    Dosage: most recent dose prior to ae onset on 08/aug/2012
    Indication: Breast Cancer
    Start date: 2012-05-05
    End date: 2012-08-14

Paclitaxel
    Dosage: most recent dose prior to ae onset on 07/aug/2012
    Indication: Breast Cancer
    Start date: 2012-05-05
    End date: 2012-08-07



Possible Herceptin side effects in female

Reported by a physician from Germany on 2012-08-21

Patient: female, weighing 77.0 kg (169.4 pounds)

Reactions: Pneumonia Cytomegaloviral

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Doxorubicin Hydrochloride
    Dosage: last dose prior to sae: 02/jul/2012
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Herceptin
    Dosage: last dose prior to sae: 18/jun/2012
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Lapatinib
    Dosage: last dose prior to sae: 14/jun/2012
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-06-14

Paclitaxel
    Dosage: last dose prior to sae: 02/jul/2012
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09



Possible Herceptin side effects in 63 year old female

Reported by a physician from United Kingdom on 2012-08-20

Patient: 63 year old female, weighing 100.0 kg (220.0 pounds)

Reactions: Myalgia, Multi-Organ Failure, Malaise, Neutropenic Sepsis, Pain, Necrotising Fasciitis

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Indication: Breast Cancer Stage I
    Start date: 2010-04-30
    End date: 2010-05-24

Docetaxel
    Dosage: dose reduced,third dose not given.

Herceptin
    Indication: Breast Cancer Stage I

Other drugs received by patient: Cyclophosphamide; Fluorouracil; Dexamethasone; Epirubicin; Tinzaparin



Possible Herceptin side effects in female

Reported by a physician from Germany on 2012-08-20

Patient: female, weighing 55.0 kg (121.0 pounds)

Reactions: General Physical Health Deterioration

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Docetaxel
    Indication: Breast Cancer
    Start date: 2012-08-01

Herceptin
    Indication: Breast Cancer
    Start date: 2012-08-01

Placebo
    Indication: Breast Cancer
    Start date: 2012-08-01



Possible Herceptin side effects in 57 year old female

Reported by a physician from Germany on 2012-08-20

Patient: 57 year old female

Reactions: Thinking Abnormal, Depression

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin



Possible Herceptin side effects in female

Reported by a consumer/non-health professional from Colombia on 2012-08-20

Patient: female

Reactions: Hyperglycaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin



Possible Herceptin side effects in female

Reported by a physician from Bosnia and Herzegowina on 2012-08-20

Patient: female, weighing 95.0 kg (209.0 pounds)

Reactions: Gastrointestinal Haemorrhage

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Herceptin



Possible Herceptin side effects in

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-08-20

Patient:

Reactions: Abdominal Pain, Vomiting, Hypersensitivity, Nausea, Skin Toxicity, Mucosal Inflammation, Fatigue, Diarrhoea, Hepatotoxicity, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Breast Cancer

Epirubicin
    Indication: Breast Cancer

Fluorouracil
    Indication: Breast Cancer

Herceptin
    Dosage: loading dose
    Indication: Breast Cancer

Herceptin
    Dosage: maintenance dose

Lapatinib
    Dosage: arm b
    Administration route: Oral
    Indication: Breast Cancer

Lapatinib
    Dosage: arm c
    Administration route: Oral

Paclitaxel
    Indication: Breast Cancer



Possible Herceptin side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-17

Patient: female

Reactions: Breast Pain, Malaise, Pruritus, Drug Ineffective, Pulmonary Oedema, Lacrimation Increased, Feeling Cold, Infusion Related Reaction

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin
    Indication: Breast Cancer
    Start date: 2006-08-01

Perjeta
    Indication: Breast Cancer

Other drugs received by patient: Tykerb; Carboplatin; Taxotere



Possible Herceptin side effects in female

Reported by a physician from Germany on 2012-08-17

Patient: female

Reactions: Right Ventricular Failure, Aortic Valve Stenosis, Left Ventricular Dysfunction, Neuropathy Peripheral, Mitral Valve Incompetence, Metastases To Bone, Aortic Valve Incompetence, Congenital Arterial Malformation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin

Other drugs received by patient: Zometa; Bisphosphonate (Unk Ingredients)



Possible Herceptin side effects in 60 year old female

Reported by a consumer/non-health professional from United States on 2012-08-17

Patient: 60 year old female, weighing 58.1 kg (127.8 pounds)

Reactions: Pneumonia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin



Possible Herceptin side effects in female

Reported by a physician from Germany on 2012-08-17

Patient: female, weighing 91.0 kg (200.2 pounds)

Reactions: General Physical Health Deterioration, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: last dose prior to 2nd episode: 13/jul/2012
    Indication: Breast Cancer
    Start date: 2012-06-01

Herceptin
    Dosage: loading dose as per protocol, last dose prior to sae : 13/jul/2012
    Indication: Breast Cancer
    Start date: 2012-06-01
    End date: 2012-06-01

Herceptin
    Dosage: estimated start date of maintenance dose. last dose prior to 1st episode: 22/jun/2012, last dose pri
    Start date: 2012-06-22

Placebo
    Dosage: loading dose as per protocol
    Indication: Breast Cancer
    Start date: 2012-06-01
    End date: 2012-06-01

Placebo
    Dosage: estimated start date of maintenance dose. last dose prior to 1st episode: 22/jun/2012, last dose pri
    Start date: 2012-06-22

Other drugs received by patient: Omeprazole; Vitamin B Complex CAP



Possible Herceptin side effects in female

Reported by a physician from France on 2012-08-17

Patient: female, weighing 56.0 kg (123.2 pounds)

Reactions: Mucosal Inflammation, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Blinded Pertuzumab
    Dosage: date of last dose rpior to sae: 01/aug/2012
    Indication: Breast Cancer
    Start date: 2012-08-01

Docetaxel
    Dosage: date of last dose prior to sae : 01/aug/2012
    Indication: Breast Cancer
    Start date: 2012-08-01

Herceptin
    Dosage: date of last dose prior to sae: 01/aug/2012
    Indication: Breast Cancer
    Start date: 2012-08-01

Other drugs received by patient: Tramadol HCL; Zofran; Acetaminophen; Fluconazole; Solu-Medrol



Possible Herceptin side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-17

Patient: female

Reactions: Pneumonia, NO Therapeutic Response, Metastases To Skin, Rash

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin
    Indication: Breast Cancer Metastatic

Xeloda
    Indication: Breast Cancer Metastatic

Other drugs received by patient: Zometa; Taxol; Navelbine; Tykerb



Possible Herceptin side effects in female

Reported by a physician from Germany on 2012-08-17

Patient: female, weighing 73.0 kg (160.6 pounds)

Reactions: Respiratory Disorder, Antibiotic Resistant Staphylococcus Test Positive

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: 38mg weekly
    Indication: Breast Cancer
    Start date: 2012-03-19

Herceptin
    Dosage: 438mg every 3 weeks
    Indication: Breast Cancer
    Start date: 2012-03-19

Lapatinib
    Dosage: 750mg per day
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-03-19

Paclitaxel
    Dosage: 153mg weekly
    Indication: Breast Cancer
    Start date: 2012-03-19

Other drugs received by patient: Ramipril; Levothyroxine Sodium



Possible Herceptin side effects in female

Reported by a physician from United States on 2012-08-17

Patient: female, weighing 57.3 kg (126.1 pounds)

Reactions: Haemorrhage Intracranial, Sepsis, Hypotension, Pneumonia Streptococcal, Failure To Thrive, Acute Respiratory Failure, Convulsion

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 167 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Herceptin
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 344 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Paclitaxel
    Dosage: last dose prior to sae: 09/mar/2012
    Indication: Breast Cancer Metastatic

Other drugs received by patient: Naproxen; Dexamethasone; Zometa; Dextrose; Ativan; Diphenhydramine HCL; Neulasta; Lortab; Robaxin; Fosphenytoin Sodium; Ciprofloxacin; Magnesium Sulfate; Lasix; Ferrous Sulfate TAB; Remeron; Artificial Tears; Amlodipine Besylate; Benadryl; Hydrocodone; Celexa; Acetaminophen; Lorazepam; Phenergan HCL; Potassium Chloride; Hydrocodone Bitartrate + Acetaminophen; Protonix; Aloxi; Mineral OIL; Insulin Aspart; Morphine Sulfate; Zofran; Cocaine; Udderly Smooth Cream



Possible Herceptin side effects in female

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-08-16

Patient: female

Reactions: Megacolon, Mydriasis, Pulmonary Embolism, Septic Shock, Sopor, Epistaxis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin

Other drugs received by patient: Fluvoxamine Maleate; Lorazepam; Abilify; Chlorpromazine HCL; Nozinan (United Kingdom); Tamoxifen Citrate



Possible Herceptin side effects in male

Reported by a physician from Korea, Republic of on 2012-08-16

Patient: male, weighing 55.0 kg (121.0 pounds)

Reactions: Pneumonia Fungal, Fatigue, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: date of most recent dose prior to sae: 18/jan/2012
    Indication: Gastric Cancer
    Start date: 2011-12-21

Herceptin
    Dosage: date of most recent dose prior to sae: 18/jan/2012, 330 mg
    Indication: Gastric Cancer
    Start date: 2011-12-21

Pertuzumab
    Dosage: date of most recent dose prior to sae: 18/jan/2012, 840 mg
    Indication: Gastric Cancer
    Start date: 2011-12-21

Xeloda
    Dosage: date of most recent dose prior to sae: 31/jan/2012
    Administration route: Oral
    Indication: Gastric Cancer
    Start date: 2011-12-21

Other drugs received by patient: Ramosetron; Artemisia Asiatica; Potassium Phosphate, Monobasic; Potassium Phosphate, Monobasic; Tramadol HCL; Albumin; Pethidine HCL; Phytonadione; Tranexamic Acid; Potassium Chloride; Potassium Phosphate, Monobasic; Albumin; Fresh Frozen Plasma; Tetracosactrin; Aprepitant; Dexamethasone; Loperamide Oxide; Megestrol Acetate; Potassium Chloride; Potassium Chloride; Potassium Phosphate, Monobasic; Albumin; Dihydrocodeine Bitartrate INJ; Methylprednisolone Sodium Succinate; Ramosetron; Lactobacillus Acidophilus; Joulie's Solution; Potassium Phosphate, Monobasic; Esomeprazole; Esomeprazole; RED Blood Cells; Aprepitant; Chlorpheniramine Maleate; Ranitidine; Ultracet; Potassium Chloride; Esomeprazole; Pethidine HCL; Remifentanil; Famotidine; Potassium Phosphate, Monobasic; Lenograstim; Bisacodyl; Magnesium Sulfate; Sodium Bicarbonate; Potassium Phosphate, Monobasic; Esomeprazole; Tramadol HCL; Albumin; Morphine HCL; Chlorpheniramine Maleate; Pethidine HCL; Dexamethasone; Potassium Chloride; Potassium Chloride; Potassium Phosphate, Monobasic; Potassium Phosphate, Monobasic; Potassium Phosphate, Monobasic; Fresh Frozen Plasma; Ketoprofen; Fentanyl Citrate



Possible Herceptin side effects in female

Reported by a physician from United States on 2012-08-16

Patient: female, weighing 57.3 kg (126.1 pounds)

Reactions: Sepsis, Pneumonia Streptococcal, Hypotension, Haemorrhage Intracranial, Acute Respiratory Failure, Failure To Thrive, Convulsion

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 167 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Herceptin
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 344 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Paclitaxel
    Dosage: last dose prior to sae: 09/mar/2012
    Indication: Breast Cancer Metastatic

Other drugs received by patient: Dexamethasone; Protonix; Zosyn; Insulin Aspart; Udderly Smooth Cream; Benadryl; Naproxen; Celexa; Aloxi; Diphenhydramine HCL; Zometa; Phenergan HCL; Acetaminophen; Fosphenytoin Sodium; Lortab; Lorazepam; Cocaine; Potassium Chloride; Ceftriaxone; Mineral OIL; Lasix; Levophed; Ferrous Sulfate TAB; Ciprofloxacin; Dextrose; Vancomycin HCL; Ativan; Neulasta; Robaxin; Artificial Tears; Hydrocodone; Remeron; Zofran; Hydrocodone Bitartrate + Acetaminophen; Magnesium Sulfate; Phenytoin Sodium



Possible Herceptin side effects in 63 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-15

Patient: 63 year old female, weighing 100.0 kg (220.0 pounds)

Reactions: Myalgia, Multi-Organ Failure, Pain, Neutropenic Sepsis, Necrotising Fasciitis, Mobility Decreased

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: 100 mg/m2, unk
    Indication: Breast Cancer Stage I
    Start date: 2010-04-30

Docetaxel
    Dosage: 75 mg/m2, unk
    End date: 2010-05-25

Herceptin
    Indication: Breast Cancer Stage I
    Start date: 2010-05-21

Other drugs received by patient: Tinzaparin; Epirubicin; Dexamethasone; Fluorouracil; Cyclophosphamide



Possible Herceptin side effects in 74 year old female

Reported by a physician from United States on 2012-08-15

Patient: 74 year old female, weighing 72.0 kg (158.4 pounds)

Reactions: Myelodysplastic Syndrome

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 600 mg/m2 iv over 30 min, on day 1 q21 dayx 4, date of last drug taken prior to onset of ae:18/jun/2
    Indication: Breast Cancer
    Start date: 2002-04-08

Doxorubicin Hydrochloride
    Dosage: 60 mg/m2 intravenous push on day 1 every21 days x 4,date of last drug taken prior to onset of ae:18/
    Indication: Breast Cancer
    Start date: 2002-04-08

Herceptin
    Dosage: 4mg/kg over 90min (loading dose) on day1 of wk13 only,2mg/kg over 30 min (maintenance dose) qwk for
    Indication: Breast Cancer
    Start date: 2002-04-08

Paclitaxel
    Dosage: 175 mg/m2 over 3 hr q 21d starting day 1 of wk 13x 4, date of last drug taken prior to onset of ae:1
    Indication: Breast Cancer
    Start date: 2002-04-08



Possible Herceptin side effects in female

Reported by a consumer/non-health professional from Peru on 2012-08-15

Patient: female

Reactions: Left Ventricular Dysfunction, Angina Pectoris, Tachycardia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin



Possible Herceptin side effects in female

Reported by a physician from Korea, Republic of on 2012-08-15

Patient: female, weighing 47.9 kg (105.4 pounds)

Reactions: Mucosal Inflammation, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: date of last dose prior to sae: 14/jun/2012
    Indication: Breast Cancer
    Start date: 2012-03-29

Herceptin
    Dosage: date of last dose prior to sae: 14/jun/2012
    Indication: Breast Cancer
    Start date: 2012-03-29

Pertuzumab
    Dosage: date of last dose prior to sae: 14/jun/2012
    Indication: Breast Cancer
    Start date: 2012-03-29

Xeloda
    Dosage: date of last dose prior to sae: 28/jun/2012
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-03-29

Other drugs received by patient: Palonosetron; Chlorpheniramine Maleate; Ircodon; Loperamide; Levofloxacin; Levofloxacin; Potassium Chloride; Spironolactone; Meropenem; Nystatin; Calcium Gluconate; Alginate Sodium; Mannitol; Metoclopramide; Furosemide; Gynobetadine; Meperidine HCL; Chlorhexidine Gluconate; Megestrol Acetate; Fentanyl; Famotidine; Potassium Dihydrogen Phosphate; Ketorolac; Dexamethasone; Pantoprazole; Albuminar-20; Meropenem; Oxytetracycline HCL; Polymyxin B Sulfate; Norepinephrine; Tetracosactrin; Almagate; Calcium Pantothenate / Cyanocobalamin / Nicotinamide / Pyridoxine Hydrochlor; Aprepitant; Aprepitant; Acetaminophen; Povidone Iodine; Pantoprazole; Pantoprazole; Morphine Sulfate; Metronidazole; Levofloxacin; Esomeprazole; Albuminar-20; Albuminar-20; Calcium Citrate with Vitamin D3; Ambroxol; Ondansetron; Dried Ferrous Sulfate; Dexamethasone; Magnesium Sulfate; Morphine Sulfate; Metoclopramide; Ambroxol; Filgrastim; Nicotinamide / Pyridoxine Hydrochloride / Riboflavin / Thiamine Hydrochlorid; Ircodon; Povidone Iodine; Mupirocin; Metronidazole; Levofloxacin; Ondansetron; Combiflex (Unk Ingredients); Metronidazole; Metronidazole; Potassium Chloride; Furosemide; Morphine HCL; Sodium Bicarbonate



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014